These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 12036895)
21. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768 [TBL] [Abstract][Full Text] [Related]
22. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Wu CJ; Chillemi A; Alyea EP; Orsini E; Neuberg D; Soiffer RJ; Ritz J Blood; 2000 Jan; 95(1):352-9. PubMed ID: 10607724 [TBL] [Abstract][Full Text] [Related]
23. Bone marrow T cells are superior to splenic T cells to induce chimeric conversion after non-myeloablative bone marrow transplantation. Park HS; Cho SG; Park MJ; Min SY; Chang HS; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Kim CC; Kim HY Korean J Intern Med; 2009 Sep; 24(3):252-62. PubMed ID: 19721863 [TBL] [Abstract][Full Text] [Related]
24. Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion. Orsini E; Bellucci R; Alyea EP; Schlossman R; Canning C; McLaughlin S; Ghia P; Anderson KC; Ritz J Cancer Res; 2003 May; 63(10):2561-8. PubMed ID: 12750280 [TBL] [Abstract][Full Text] [Related]
25. Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity. Peggs KS; Mackinnon S; Williams CD; D'Sa S; Thuraisundaram D; Kyriakou C; Morris EC; Hale G; Waldmann H; Linch DC; Goldstone AH; Yong K Biol Blood Marrow Transplant; 2003 Apr; 9(4):257-65. PubMed ID: 12720218 [TBL] [Abstract][Full Text] [Related]
26. Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation. Meyer RG; Wagner EM; Konur A; Bender K; Schmitt T; Hemmerling J; Wehler D; Hartwig UF; Roosnek E; Huber C; Kolbe K; Herr W Bone Marrow Transplant; 2010 Apr; 45(4):668-74. PubMed ID: 19684624 [TBL] [Abstract][Full Text] [Related]
27. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism. Mapara MY; Kim YM; Marx J; Sykes M Transplantation; 2003 Jul; 76(2):297-305. PubMed ID: 12883182 [TBL] [Abstract][Full Text] [Related]
28. Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leda M; Ladon D; Pieczonka A; Boruczkowski D; Jólkowska J; Witt M; Wachowiak J Leuk Res; 2001 Apr; 25(4):353-7. PubMed ID: 11248334 [TBL] [Abstract][Full Text] [Related]
29. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. Xia G; Truitt RL; Johnson BD Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723 [TBL] [Abstract][Full Text] [Related]
30. Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. Billiau AD; Fevery S; Rutgeerts O; Landuyt W; Waer M Blood; 2002 Sep; 100(5):1894-902. PubMed ID: 12176914 [TBL] [Abstract][Full Text] [Related]
31. Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells. Sefrioui H; Billiau AD; Waer M Transplantation; 2000 Jul; 70(2):348-53. PubMed ID: 10933162 [TBL] [Abstract][Full Text] [Related]
32. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Johnson BD; Konkol MC; Truitt RL Biol Blood Marrow Transplant; 2002; 8(10):525-35. PubMed ID: 12434947 [TBL] [Abstract][Full Text] [Related]